Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 72888-032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 72888-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg Tablet Bottle Label (NDC 72888-031-01)

10 mg Tablet Bottle Label (NDC 72888-031-01)
This text describes a medication known as Oxybutynin Chloride USP, which is available in Extended-Release tablets containing 10 mg of the active ingredient. The typical dosage and storage conditions are indicated, including the need for a child-resistant container and protection from moisture and humidity. The medication should also be kept out of children's reach. The label includes a product code, manufacturing information, and distribution contact information.*
FDA Label Image

15 mg Tablet Bottle Label (NDC 72888-032-01)

15 mg Tablet Bottle Label (NDC 72888-032-01)
Each Extended-Release Tablet contains 15mg Oxybutynin Chloride USP. The medication is distributed by Advager Pharma Limited and manufactured by E\lult)icon Pvt. Ltd. The package insert contains dosage and other important information. The tablets are manufactured in Thane, India and the manufacturing license number is KD-682. It is recommended to store the tablets in a well-closed container with child-resistant closure at controlled room temperature. Protect the medication from moisture and humidity and keep it out of reach of children. No additional information is available.*
FDA Label Image

5 mg Tablet Bottle Label (NDC 72888-030-01)

5 mg Tablet Bottle Label (NDC 72888-030-01)
This is a medication bottle containing extended-release tablets of Oxybutynin Chloride USP 5mg. It states to store the medication at 25°C (77°F), protect it from moisture and to keep it out of the reach of children. The tablets are distributed by Advagen Pharma Ltd. with the manufacturer being Rubicon Research Pvt. Ltd. from Ambernath, India. There is also a dosage information label along with the National Drug Code (NDC) number and other details.*
FDA Label Image

Figure 1 (Oxybutynin Chloride Er Tab Usp Fig 1)

Figure 1 (Oxybutynin Chloride Er Tab Usp Fig 1)
This text seems to describe medication instructions for oxybutynin, with a recommended dosage of 10mg once a day for the extended-release version (ER) and 5mg three times a day for the non-ER version. The rest of the text is not useful or readable, so a more detailed description cannot be provided.*
FDA Label Image

Figure 2 (Oxybutynin Chloride Er Tab Usp Fig 2)

Figure 2 (Oxybutynin Chloride Er Tab Usp Fig 2)
FDA Label Image

Figure 3 (Oxybutynin Chloride Er Tab Usp Fig 3)

Figure 3 (Oxybutynin Chloride Er Tab Usp Fig 3)
FDA Label Image

Figure 4 (Oxybutynin Chloride Er Tab Usp Fig 4)

Figure 4 (Oxybutynin Chloride Er Tab Usp Fig 4)
FDA Label Image

Figure 5 (Oxybutynin Chloride Er Tab Usp Fig 5)

Figure 5 (Oxybutynin Chloride Er Tab Usp Fig 5)
Oxybutynin ER is a medication used to treat overactive bladder.*
FDA Label Image

Chemical Structure (Oxybutynin Chloride Er Tab Usp Structure)

Chemical Structure (Oxybutynin Chloride Er Tab Usp Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.